Pfizer Inc (NYSE:PFE)
| 33.48 Delayed Data As of Feb 26 |  -0.34 / -1.01%Today’s Change | 26.43 Today|||52-Week Range 43.08 | -9.05% Year-to-Date |
Latest PFE News | Press Releases
| What Warren Buffett Has Been Buying and Selling Feb 26 / MotleyFool.com - Paid Partner Content | Johnson & Johnson vs. Novavax: Which Vaccine Is Best Against New Strains? Feb 26 / MotleyFool.com - Paid Partner Content |
| Top 5 4th-Quarter Trades of Chris Davis' Firm Feb 26 / GuruFocus News - Paid Partner Content | 3 Popular Stocks Billionaires Can't Stop Selling Feb 26 / MotleyFool.com - Paid Partner Content |
| Pharma Stock Roundup: SNY/GSK & PFE COVID-19 Vaccine Update, MRK's Pandion Buyout Feb 26 / Zacks.com - Paid Partner Content | What Are the Risks for Moderna Shareholders? Feb 25 / MotleyFool.com - Paid Partner Content |
| Oil is up nearly 70% since the election, a record in the modern era Feb 26 / CNN.com - Paid Partner Content | 1 Green Flag for Moderna Stock Feb 25 / MotleyFool.com - Paid Partner Content |
| Should You Buy Ocugen for Its COVID Vaccine? Feb 26 / MotleyFool.com - Paid Partner Content | Is West Pharmaceutical Services Stock a Smart Investment? Feb 25 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 33.82 |
| Today’s open | 33.80 |
| Day’s range | 33.36 - 33.83 |
| Volume | 41,462,750 |
| Average volume (3 months) | 42,647,633 |
| Market cap | $191.5B |
Data as of 6:08pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | -40.76% |
| Earnings growth (this year) | +44.05% |
| Earnings growth (next 5 years) | +10.46% |
| Revenue growth (last year) | -19.02% |
| P/E ratio | 21.6 |
| Price/Sales | 4.95 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | -1.97 | -2.64% |
| ABBVAbbVie | +0.40 | +0.37% |
| LLYEli Lilly and Co | +0.89 | +0.44% |
| NVSNovartis | -0.80 | -0.92% |
Data as of 4:50pm ET, 02/26/2021
Financials
| Next reporting date | May 4, 2021 |
| EPS forecast (this quarter) | $0.78 |
| Annual revenue (last year) | $41.9B |
| Annual profit (last year) | $9.6B |
| Net profit margin | 16.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
